Dr. Weyrich's Naturopathic Functional Medicine Notebook is a collection of information on topics of interest to Dr. Weyrich that may be of interest to the world wide audience. Due to limitations of time, not all information that Dr. Weyrich knows or would like to further research is published here. Dr. Weyrich welcomes financial contributions to support specific research topics, as well as copies of non-free access journal articles for him to review on a topic. Constructive criticism is also welcome.

Overview of Endometrial Cancer

This web page discusses ovarian cancer, which appears to have different mechanisms than breast and prostate cancer.

Please see Cancer Overview for general information that is common to all forms of cancer.

Dr. Weyrich is not an expert in the treatment of cancer, but does offer supportive therapies to reduce pain and nausea, mitigate the side effects, and to generally boost the immune system.

Complimentary and alternative treatments for endometrial cancer that are considered below include:

  • Low Dose Naltrexone

Etiology of Endometrial Cancer

[Friedman2013] has presented a compelling model for the prevention and treatment of breast and prostate cancer. An important feature of this model is observation that synthetic (non-bio-identical) estrogens and progestins actually raise the risk of breast and prostate cancer. On the other hand, it appears [Go to cancer.govcancer.gov], synthetic hormones in oral contraceptives actually reduce the incidence of certain endometrial cancers [Emons2000].

The differences between different types of cancers require further study.

Hypotheses regarding Endometrial Cancer

Please see conventional, complimentary and alternative medical treatments for important background information regarding the different types of medical treatments discussed below.

Naturopathic, Complimentary and Alternative Treatments

Low Dose Naltrexone (LDN)

[LDN_Cancer] reports that the late Dr. Bernard Bihari treated approximately 450 patients with some form of cancer, with a 60% success rate, almost all of who had failed to respond to standard treatments. Although Dr. Weyrich is not aware of any reports of treating endometrial cancer using LDN, Dr. Weyrich speculates that endometrial cancer may also respond to LDN.

Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN). However, Dr. Weyrich has not treated any cases of endometrial cancer with LDN.

Please see What is Low Dose Naltrexone? for more information.

References for Endometrial Cancer